Welcome, Guest. Please login or register.
July 18, 2024, 04:33:31 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 203
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 82
Total: 82


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Does Hepatitis B Treatment Lower the Risk of Liver Cancer?  (Read 9295 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Does Hepatitis B Treatment Lower the Risk of Liver Cancer?
« on: July 21, 2017, 10:41:58 am »
Over the long term, antiviral treatment for hepatitis B virus (HBV) should reduce the number of people who develop hepatocellular carcinoma (HCC), a form of primary liver cancer. But in the meantime, a decline in deaths due to other types of liver disease, such as decompensated cirrhosis, could mean that more people with hepatitis B will live long enough to develop liver cancer.

These paradoxical findings come from two studies recently published in Hepatology. A European study found that the risk of developing HCC decreased after five years of treatment with Viread (tenofovir disoproxil fumarate) or Baraclude (entecavir). But a Korean study found that while overall liver disease mortality has fallen dramatically since the debut of the first antivirals for HBV, liver cancer deaths continue to increase.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.